Executive Team

HOME Michael McCrory Chairman

Mr. McCrory has worked in the securities industry since 1995, prior to which he spent over 10 years as an executive in the insurance industry. He has lived in Italy since 1994 and worked with institutional investors throughout Europe. In addition to serving in his capacity at I-Bankers Securities he serves on the Board of Directors of various other companies. Mr. McCrory has been securities licensed since 1992 and holds both a Series 7 and Series 24 license. He holds a BSBA from the University of Phoenix and an MBA from the Owen Graduate School of Management at Vanderbilt University.

HOME Shelley Leonard President & CFO

Shelley co-founded the firm in 1996. Prior to that she served in various capacities of operations, finance, and compliance in the insurance and securities industry, including four years as CFO and Director for Commercial Life & Accident Insurance Co. In addition to her management of I-Bankers Securities she also serves as CFO and Director of I-Bankers Direct, LLC. Her BS degree in International Business is from Regents College and her MBA is from Southern Methodist University. She holds Series 7, 24, 27 and 63 securities licenses.

HOME Paolo Floriani Chief European Advisor, Director

After achieving a master's degree in Management and Auditing from Bocconi University in Milan, Mr. Floriani spent six years as Director of Investments of PRIVEST. During 1991 he became a Qualified Swiss Corporate Advisor and Trustee, and acted as partner and director in many international holding and finance corporations. His experience includes banking, corporate finance, and real estate investments. A native Italian, Mr. Floriani brings an extensive European client base.

HOME Christine Murphy CCO

Christine A Murphy has been working in the securities industry for over 25 years in all areas of the Broker Dealer Industry with 10 years in the RIA Industry. Ms. Murphy has been conducting consulting for broker/dealers, consultants and RIAs for over 15 years. She holds Series 7, 63, 4, 24, 55, 27, 28 and 99 securities licenses.

HOME B. Andrew Miles Managing Director

Andy has 17 years of global finance, private equity, business development and operational experience, including eight years in the pharmaceutical industry, working within the sales and marketing organizations of Eli Lilly & Company. Prior to joining I-Bankers Direct and I-Bankers Securities, Andy was a Managing Director with Roberts Mitani, a global diversified advisory and investment banking firm where he focused primarily on advisory mandates, private placements and PIPEs. Andy has managed and co-managed the financing process for many portfolio companies and management teams. He has partnered with companies and investors in global private equity markets, mainly in the life sciences and healthcare sectors, where he has cultivated relationships worldwide. Andy has a BA from Dickinson College and an MA from Middlebury College.

HOME Michael Marshall Managing Director

Mike has 30 years of experience in equity and debt capital markets. He began his career at Salomon Brothers where he held a variety of positions spanning 18 years in Corporate Bond Trading, Liability Management, Pension Services, and Emerging Markets. He then led the private placement effort at Needham & Company, a boutique investment bank that serves technology and life sciences companies, for eight years. Immediately prior to joining I-Bankers Securities, Mike directed the private placement business at The Northstar Group. Mike holds an M.B.A. from the Columbia Graduate School of Business and an undergraduate degree from Oklahoma State University.

HOME Silvia Panigone Advisor

In addition to her role at I-Bankers Direct, Silvia is also a board member of several biotech and medtech companies, and a corporate finance member of XoVenture, an international network dedicated to building life sciences companies in a cost-effective manner. Silvia formerly served as an Advisor in the Investment Banking division of BSI bank after serving as Investment Director of BSI Healthcapital, a venture capital firm and member of the Generali group. She possesses extensive experience in the drug development & diagnostic sectors, having served in operational and managerial positions with Bracco SpA and Quintiles Inc. as well as in academia. Silvia is also a member of the BioInItaly Evaluation Committee (sponsored by Intesa San Paolo and Assobiotech). She has a PhD in Molecular Oncology, and a Management of Economical Resources Certificate from SDA Bocconi.